An integrated incentive-based treatment to optimize HIV treatment engagement among persons who use methamphetamine
基于激励的综合治疗,以优化甲基苯丙胺使用者的艾滋病毒治疗参与度
基本信息
- 批准号:10609449
- 负责人:
- 金额:$ 20.57万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2021
- 资助国家:美国
- 起止时间:2021-05-01 至 2026-04-30
- 项目状态:未结题
- 来源:
- 关键词:AbstinenceAddressAdherenceAreaBehavior TherapyBiologicalCaringClinical TrialsContinuity of Patient CareDevelopmentDevelopment PlansEffectivenessEpidemicEvaluationEvidence based practiceEvidence based treatmentFive-Year PlansGoalsHIVHealth ServicesIncentivesIndividualInterventionInvestmentsKnowledgeLinkMentored Patient-Oriented Research Career Development AwardMentorsMethamphetamine use disorderMethodologyMethodsModelingNIH Office of AIDS ResearchNational Institute of Drug AbuseOperant ConditioningPatient-Focused OutcomesPersonsPositioning AttributePositive ReinforcementsPredispositionPrizeProcessProviderPublic HealthRandomizedRecommendationRegimenReportingResearchResearch ActivityResearch PersonnelResearch PriorityResearch Project GrantsResourcesScienceStrategic PlanningSubstance Use DisorderSystemTargeted ResearchTestingToxicologyTrainingTraining ActivityTraining ProgramsUrineaddictionantiretroviral therapycareercareer developmentcombatcomorbiditycontingency managementdesigneffective interventioneffectiveness evaluationevidence baseexperiencefallshealth goalsimplementation frameworkimplementation scienceimprovedimproved outcomeincentive-based interventionmethamphetamine effectmethamphetamine usenovelpatient engagementprogramspsychosocialskillsstimulant usesubstance usesuccesstherapy adherencetransmission process
项目摘要
PROJECT SUMMARY/ABSTRACT
The objective of this K23 Mentored Patient-Oriented Research Career Development Award is to assist the
candidate in acquiring expertise and methodological skills to become an independent implementation science
investigator focused on integrated substance use disorder and HIV care practices. The objective of the
candidate’s research is two-fold: to reduce the detrimental impact of methamphetamine use while simultaneously
supporting engagement in HIV care. People with HIV who use methamphetamine are susceptible to experiencing
gaps at each stage of the HIV care continuum. Contingency management is an effective behavioral therapy for
methamphetamine use disorder that is based on operant conditioning principles. Contingency management
decreases the reinforcing effects of methamphetamine use by providing immediate, positive reinforcement
following abstinence from substance use. Incentive-based interventions based on operant conditioning principles
also demonstrate positive effects for improving antiretroviral therapy (ART) adherence. It remains unclear
whether a contingency management program that integrates incentives for ART adherence (CM+ART, i.e.,
dually targeting methamphetamine use and ART adherence) is more acceptable and appropriate to people with
HIV than a contingency management program targeting methamphetamine use only. The specific aims of the
research plan for the five-year K23 award period are: 1) to identify resources required to implement contingency
management programs in settings serving people with HIV, 2) to adapt contingency management to integrate
incentives for adherence to ART (CM+ART), and 3) to evaluate whether CM+ART is acceptable and appropriate
to people with HIV who use methamphetamine compared to a contingency management program targeting only
reductions in methamphetamine use. Dr. Montoya’s mentored training plan, including formal didactics and other
activities, aligns with the research aims and career development plans and has four key areas: 1) to deepen
knowledge of evidence-based practices implemented at local and national levels to support patient engagement
in HIV and substance use disorder care, 2) to apply an implementation science approach to guide adaptation of
contingency management to integrate incentives for ART adherence, 3) to acquire advanced methodological
skills to design and evaluate mixed-method studies and clinical trials, and 4) to engage in professional
development activities geared toward development of a competitive NIDA R01 application and an independent
research career. This proposal strongly aligns with NIDA Strategic Plan Objectives 3.1 (“Develop and test novel
treatments based on the science of addiction”) and 3.4 (“Develop and test strategies for effectively and
sustainably implementing evidence-based treatments”); the NIH Office of AIDS Research priority to address HIV-
associated comorbidities such as substance use disorders; and the “Ending the HIV Epidemic: A Plan for
America” initiative. The comprehensive training activities and research plan will effectively position the candidate
for an independent research career focused on the integration of HIV and substance use disorder care.
项目总结/摘要
这个K23指导以患者为导向的研究职业发展奖的目的是帮助
候选人获得专业知识和方法技能,成为一个独立的实施科学
调查人员集中在综合药物使用障碍和艾滋病毒护理做法。的目的
候选人的研究是双重的:减少甲基苯丙胺使用的有害影响,同时
支持参与艾滋病毒护理。使用甲基苯丙胺的艾滋病毒感染者容易经历
艾滋病毒护理连续体每个阶段的差距。应急管理是一种有效的行为疗法,
基于操作性条件反射原理的甲基苯丙胺使用障碍。权变管理
通过提供即时的、积极的强化来减少甲基苯丙胺使用的强化效果
在戒除药物使用之后。基于操作性条件反射原则的激励干预
也显示出对改善抗逆转录病毒疗法(ART)依从性的积极作用。目前还不清楚
整合ART依从性激励的应急管理计划(CM+ART,即,
双重目标甲基苯丙胺的使用和ART坚持)是更容易接受和适当的人,
而不是一个只针对甲基苯丙胺使用的应急管理计划。的具体目标
五年K23奖励期的研究计划是:1)确定实施应急计划所需的资源
在为艾滋病毒感染者服务的环境中实施管理方案,2)调整应急管理,
鼓励坚持ART(CM+ART),3)评估CM+ART是否可接受和适当
与仅针对使用甲基苯丙胺的艾滋病毒感染者的应急管理计划相比,
减少甲基苯丙胺的使用。蒙托亚博士的指导培训计划,包括正式的教学法和其他
活动,符合研究目标和职业发展计划,并有四个关键领域:1)深化
了解在地方和国家层面实施的循证实践,以支持患者参与
在艾滋病毒和药物使用障碍护理方面,2)采用科学方法指导
应急管理,以整合ART依从性的激励措施,3)获得先进的方法
设计和评估混合方法研究和临床试验的技能,以及4)从事专业
开发活动旨在开发具有竞争力的NIDA R 01应用程序和独立的
研究生涯。该提案与NIDA战略计划目标3.1(“开发和测试新的
和3.4(“制定和测试有效和有效的治疗策略,
可持续地实施循证治疗”);美国国立卫生研究院艾滋病研究办公室优先解决艾滋病毒-
相关的合并症,如物质使用障碍;和“结束艾滋病毒流行病:
美国”倡议。全面的培训活动和研究计划将有效地定位候选人
一个独立的研究生涯,专注于艾滋病毒和物质使用障碍护理的整合。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Jessica Lynette Montoya其他文献
Jessica Lynette Montoya的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Jessica Lynette Montoya', 18)}}的其他基金
An integrated incentive-based treatment to optimize HIV treatment engagement among persons who use methamphetamine
基于激励的综合治疗,以优化甲基苯丙胺使用者的艾滋病毒治疗参与度
- 批准号:
10161337 - 财政年份:2021
- 资助金额:
$ 20.57万 - 项目类别:
An integrated incentive-based treatment to optimize HIV treatment engagement among persons who use methamphetamine
基于激励的综合治疗,以优化甲基苯丙胺使用者的艾滋病毒治疗参与度
- 批准号:
10398190 - 财政年份:2021
- 资助金额:
$ 20.57万 - 项目类别:
相似海外基金
Pharmacy-led Transitions of Care Intervention to Address System-Level Barriers and Improve Medication Adherence in Socioeconomically Disadvantaged Populations
药房主导的护理干预转型,以解决系统层面的障碍并提高社会经济弱势群体的药物依从性
- 批准号:
10594350 - 财政年份:2023
- 资助金额:
$ 20.57万 - 项目类别:
Evaluating Centralizing Interventions to Address Low Adherence to Lung Cancer Screening Follow-up in Decentralized Settings
评估集中干预措施,以解决分散环境中肺癌筛查随访依从性低的问题
- 批准号:
10738120 - 财政年份:2023
- 资助金额:
$ 20.57万 - 项目类别:
Suubi-Mhealth: A mobile health intervention to address depression and improve ART adherence among Youth living with HIV (YLHIV) in Uganda
Suubi-Mhealth:一种移动健康干预措施,旨在解决乌干达艾滋病毒感染者 (YLHIV) 青少年的抑郁症问题并提高抗逆转录病毒疗法的依从性
- 批准号:
10526768 - 财政年份:2022
- 资助金额:
$ 20.57万 - 项目类别:
Suubi-Mhealth: A mobile health intervention to address depression and improve ART adherence among Youth living with HIV (YLHIV) in Uganda
Suubi-Mhealth:一种移动健康干预措施,旨在解决乌干达艾滋病毒感染者 (YLHIV) 青少年的抑郁症问题并提高抗逆转录病毒疗法的依从性
- 批准号:
10701072 - 财政年份:2022
- 资助金额:
$ 20.57万 - 项目类别:
A behavioral intervention for Black men who have sex with men and live with HIV to address intersectional stigma and improve antiretroviral therapy adherence
针对男男性行为且感染艾滋病毒的黑人男性进行行为干预,以解决交叉耻辱并提高抗逆转录病毒治疗的依从性
- 批准号:
10679092 - 财政年份:2021
- 资助金额:
$ 20.57万 - 项目类别:
A behavioral intervention for Black men who have sex with men and live with HIV to address intersectional stigma and improve antiretroviral therapy adherence
针对男男性行为且感染艾滋病毒的黑人男性进行行为干预,以解决交叉耻辱并提高抗逆转录病毒治疗的依从性
- 批准号:
10432133 - 财政年份:2021
- 资助金额:
$ 20.57万 - 项目类别:
A behavioral intervention for Black men who have sex with men and live with HIV to address intersectional stigma and improve antiretroviral therapy adherence
针对男男性行为且感染艾滋病毒的黑人男性进行行为干预,以解决交叉耻辱并提高抗逆转录病毒治疗的依从性
- 批准号:
10327065 - 财政年份:2021
- 资助金额:
$ 20.57万 - 项目类别:
Leveraging Technology to Address Access and Adherence to Conventional Hospital-Based Pulmonary Rehabilitation in Veterans with COPD
利用技术解决慢性阻塞性肺病退伍军人接受和坚持传统医院肺康复的问题
- 批准号:
10377366 - 财政年份:2019
- 资助金额:
$ 20.57万 - 项目类别:
Leveraging Technology to Address Access and Adherence to Conventional Hospital-Based Pulmonary Rehabilitation in Veterans with COPD
利用技术解决慢性阻塞性肺病退伍军人接受和坚持传统医院肺康复的问题
- 批准号:
10574496 - 财政年份:2019
- 资助金额:
$ 20.57万 - 项目类别:
Targeted interventions to address the multi-level effects of gender-based violence on PrEP uptake and adherence among adolescent girls and young women in Kenya
有针对性的干预措施,以解决性别暴力对肯尼亚少女和年轻妇女接受和坚持 PrEP 的多层面影响
- 批准号:
9403567 - 财政年份:2017
- 资助金额:
$ 20.57万 - 项目类别: